New heart catheter aims to zap dangerous rhythms safely

NCT ID NCT05543798

Recruiting now Disease control Sponsor: Imricor Medical Systems Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new catheter (Vision-MR 2.0) to treat ventricular tachycardia, a fast, dangerous heart rhythm, in people with ischemic heart disease. About 64 adults will undergo a procedure to burn small areas of heart tissue causing the abnormal rhythm. The goal is to stop the arrhythmia without serious side effects, but ongoing medication or future episodes may still occur.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTRICULAR TACHYCARDIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Amsterdam UMC
RECRUITING

Amsterdam, Netherlands

Contact Phone: •••-•••-•••• Email: •••••@•••••
HagaZiekenhuis
NOT_YET_RECRUITING

The Hague, 2545 AA, Netherlands

Contact

Contact
Herzzentrum Leipzig
NOT_YET_RECRUITING

Leipzig, Saxony, 04289, Germany

Contact